Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 7,975 | 8,657 | 10,865 | 11,951 | 146 |
| Operating Income | -7,975 | -8,657 | -10,865 | -11,951 | -146 |
| Other Income | -7,063 | 8,536 | 35 | -36 | -1,485 |
| Pre-tax Income | -15,039 | -120 | -10,830 | -11,987 | -1,631 |
| Net Income Continuous | -15,039 | -120 | -10,830 | -11,987 | -1,631 |
| Net Income | $-15,039 | $-120 | $-10,830 | $-11,987 | $-1,631 |
| EPS Basic Total Ops | -1,052.27 | -101.29 | -28,649.27 | -245,069.50 | -0.68 |
| EPS Basic Continuous Ops | -1,049.31 | -103.09 | -28,642.99 | -245,107.10 | -0.68 |
| EPS Diluted Total Ops | -1,052.27 | -101.29 | -28,649.27 | -245,069.50 | -0.68 |
| EPS Diluted Continuous Ops | -1,049.31 | -103.09 | -28,642.99 | -245,107.10 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -552.30 | -7,097.03 | -115,845.80 | -235,895.80 | N/A |
| EBITDA(a) | $-7,947 | $-8,632 | $-10,840 | $-11,934 | $-146 |